Press Release

Generics Outlook Appears Sluggish

January 4th, 2011

Global Information Inc. would like to present a new market research report, "Generic Market Outlook: 2015" by Datamonitor.

Between 2005 and 2009, the generics industry posted compound annual growth rates (CAGR) of 10.3 percent with strong revenues. The global generics market was estimated to be worth nearly $80 billion in 2009. This industry has evolved considerably in the last decade. According to Datamonitor, "it has become and increasingly integral element of the prescription pharmaceutical sector and helped by aggressive M&A strategies..."

While the generics industry has exhibited strong growth in recent years, Datamonitor forecasts that sales growth will start to decline between the 2009 and 2015 period with a compound annual growth rate (CAGR) of 5 percent. "Sales growth has been driven by two key factors; growing demand for cheaper pharmaceuticals as a means to contain healthcare expenditure and a succession of patent expirations on heavily prescribed branded blockbuster products, which the generics industry has capitalized on," notes Simon King, a pharmaceutical analyst for Datamonitor.

Close analysis conducted by Datamonitor has revealed that a deceleration in sales growth will be the likely trend from 2012 onwards. The global CAGR for the 2012 to 2015 forecast period is expected to be 3.7 percent. "In short, the level of branded revenues associated with blockbuster products that have become exposed to the generics industry via patent expiration will begin to decrease sharply from 2012 onwards," according to Simon King. "This sharp decline  driven partly by a fall in Big Pharmas blockbuster productivity over the past decade  will deprive the generic industry of significant revenue injections. The end of this golden era of patent expiries will fundamentally shift the generics landscape as sections of the wider pharmaceutical market become more commoditized."

Datamonitors report will help you assess the outlook for the generics industry through 2015 and evaluate the effects of the end of Big Pharmas blockbuster era on the generics industry. Readers will gain analyses of historical and forecast generics sales by geography, therapy area, formulation, and company from this report.

Global Information Inc.(GII) - specializing in market research provision for the vertical industries, GII offers expert independent recommendations of publications from hundreds of the globe's leading market research firms.

Product Code : 142033